Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Cardiology Reports
|
March 4, 2022
Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses
Brian Yu, Shane Rui Zhao, Christopher D Yan, et al.
Journal of Visualized Experiments : Jove
|
August 22, 2022
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Shane Rui Zhao, Gema Mondéjar-Parreño, Dong Li, et al.
Stem Cell Research
|
December 15, 2023
Generation of induced pluripotent stem cell lines from South Asian ethnicity
Yaser Khokhar, Ava Bhowmik, Shane Rui Zhao, et al.
STAR Protocols
|
November 8, 2021
Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes
Joe Z Zhang, Shane Rui Zhao, Chengyi Tu, et al.
STAR Protocols
|
April 29, 2023
Protocol to generate cardiac pericytes from human induced pluripotent stem cells
Mengcheng Shen, Shane Rui Zhao, Yaser Khokhar, et al.
Stem Cell Research
|
November 19, 2021
Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations
Shane Rui Zhao, Mengcheng Shen, Chelsea Lee, et al.
Stem Cell Research
|
October 21, 2022
Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
Tina Tianbo Zhang, Shane Rui Zhao, Christina Alamana, et al.
Science Advances
|
February 23, 2022
Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy
Suet Nee Chen, Chi Keung Lam, Ying-Wooi Wan, et al.
Cell Stem Cell
|
November 8, 2024
CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity
Chun Liu, Mengcheng Shen, Yanxia Liu, et al.
Science Translational Medicine
|
January 25, 2023
SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common <i>ALDH2</i> alcohol flushing variant
Hongchao Guo, Xuan Yu, Yu Liu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Cardiology Reports
|
March 4, 2022
Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses
Brian Yu, Shane Rui Zhao, Christopher D Yan, et al.
Journal of Visualized Experiments : Jove
|
August 22, 2022
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Shane Rui Zhao, Gema Mondéjar-Parreño, Dong Li, et al.
Stem Cell Research
|
December 15, 2023
Generation of induced pluripotent stem cell lines from South Asian ethnicity
Yaser Khokhar, Ava Bhowmik, Shane Rui Zhao, et al.
STAR Protocols
|
November 8, 2021
Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes
Joe Z Zhang, Shane Rui Zhao, Chengyi Tu, et al.
STAR Protocols
|
April 29, 2023
Protocol to generate cardiac pericytes from human induced pluripotent stem cells
Mengcheng Shen, Shane Rui Zhao, Yaser Khokhar, et al.
Stem Cell Research
|
November 19, 2021
Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations
Shane Rui Zhao, Mengcheng Shen, Chelsea Lee, et al.
Stem Cell Research
|
October 21, 2022
Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
Tina Tianbo Zhang, Shane Rui Zhao, Christina Alamana, et al.
Science Advances
|
February 23, 2022
Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy
Suet Nee Chen, Chi Keung Lam, Ying-Wooi Wan, et al.
Cell Stem Cell
|
November 8, 2024
CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity
Chun Liu, Mengcheng Shen, Yanxia Liu, et al.
Science Translational Medicine
|
January 25, 2023
SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common <i>ALDH2</i> alcohol flushing variant
Hongchao Guo, Xuan Yu, Yu Liu, et al.
Page
of 2